RxDoctor Payments Data

Thomas Chauncey

Hematology & Oncology · Seattle, WANPI 1710077243

Payments from drug & device makers

$364,692in general payments, 2019–2025

Across 44 payments — averaging $8288.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$214K
  • Shire North American Group Inc$67K
  • Takeda Pharmaceuticals U.S.A., Inc.$51K
  • Janssen Research & Development, LLC$25K
  • Helsinn Healthcare SA$6K
  • GSK$2K
  • plus $686 from 2 others

What the payments were for

  • Consulting fees$65095%
  • Food & beverage$365%

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$364,692 in reported general payments places this provider in the 75th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Other hematology & oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →